Thursday, June 15, 2023 11:22:36 AM
OCUP $3.75 -FDA Decision in September followed by Phase results for another indication . Market cap $79 m - Cash $39 m enough untill mid 2025 potential milestone payment of $10 million upon FDA approval not included . The Drug is already partnered with Viatris (VTRS) . A very cheap FDA play here ...
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
